SCHEMBL19202425

SCHEMBL19202425

OC1c2ccc3c(oc4ccccc43)c2-c2c1ccc1c2sc2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.39
▸ ESR1 P03372 1/20 0.35
▸ ALOX5 P09917 4/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ PRKDC P78527 5/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ PARP14 Q460N5 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ PIK3CD O00329 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ MTOR P42345 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ BRDT Q58F21 1/20 0.31
▸ PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17431198 0.80 ESR2 (0.40) ESR2ESR1ALOX5PGRPRKDC
SCHEMBL17689908 0.79 ESR2 (0.49) ESR2ESR1ALOX5MEN1KMT2A
SCHEMBL19419237 0.79 ESR2 (0.46) ESR2ESR1ALOX5MEN1KMT2A
SCHEMBL18566661 0.75 ESR2 (0.42) ESR2ESR1ALOX5PGRPRKDC
SCHEMBL19803007 0.74 PRKDC (0.50) ESR2ESR1ALOX5PRKDCGPR3
SCHEMBL18566660 0.73 PARP14 (0.42) ESR2ESR1ALOX5PRKDCPARP14
SCHEMBL9890859 0.73 ALOX5 (0.43) ESR2ESR1ALOX5PRKDCGPR3
SCHEMBL20247042 0.73 ALOX5 (0.38) ESR2ALOX5MEN1CYP2C19KMT2A
SCHEMBL17039877 0.72 PRKDC (0.49) ESR2ESR1ALOX5PRKDCGPR3
SCHEMBL21583609 0.72 PRKDC (0.49) ESR2ESR1ALOX5PRKDCGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170222155-A1 CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING SFC CO., LTD. (KR) 2017-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170222155-A1 CONDENSED FLUORENE DERIVATIVE COMPRISING HETEROCYCLIC RING CCNE2, INF2, AFF4 ESR2 842/4885ESR1 230/4885ALOX5 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback